—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
Clinical and Translational Gastroenterology《临床与转化胃肠病学》
月刊 - 美国
  • Clinical and Translational Gastroenterology《临床与转化胃肠病学》
  • SCIE外文期刊
  • 期发文量11
  • 国人占比24.24%
  • 知网外文库
  • 投稿方式--官网投稿
  • 期刊属性

  • 中科分区:3区
    OA期刊:
  • 综述期刊:
    TOP期刊:
  • 期均国文:3
    环比增速:0.00%
  • 期刊信息

  • 研究方向:医学-GASTROENTEROLOGY HEPATOLOGY胃肠肝病学
  • 国际刊号:ISSN 2155-384X;EISSN 2155-384X
  • 期刊语言:英语
    出版地区:美国
  • 投稿网址:https://www.editorialmanager.com/ctg
  • 电子邮箱:
  • 期刊官网:https://journals.lww.com/ctg/pages/default.aspx
  • 作者指南:
  • 出版商网址:http://www.lww.com/
  • 出版地址:TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, USA, PA, 19103
  • 期刊简介:Clinical and Translational Gastroenterology《临床与转化胃肠病学》(月刊). Clinical and Translational Gastroenterology (CTG), published on behalf of the American College of Gastroenterology (ACG), is a peer-reviewed open access online journal dedicated to innovative clinical work in the field of gastroenterology and hepatology.

  • 万维提示


  • 1、投稿方式:在线投稿。

    2、期刊网址:

    https://journals.lww.com/ctg/pages/default.aspx

    3、投稿网址:https://www.editorialmanager.com/ctg

    4、官网邮箱:journals@gi.org

    5、官网电话:301-263-9000

    6、期刊刊期:月刊,一年出版12期。

    2022117日星期一

                                  

     

    投稿须知【官网信息】

     

    Instructions for Authors

    Clinical and Translational Gastroenterology (CTG)

    MISSION

    To improve the health and well-being of individuals worldwide impacted by digestive disorders.

    AIMS AND SCOPE

    Clinical and Translational Gastroenterology (CTG), published on behalf of the American College of Gastroenterology (ACG), is a double-blind peer-reviewed, open access, online journal dedicated to innovative clinical work in the field of gastroenterology, pancreatology, and hepatology. CTG  seeks to promptly publish and broadly disseminate important clinical care insights and significant scientific discoveries that impact the prevention, diagnosis, and treatment of digestive disorders. CTG hopes to fulfill an unmet need for clinicians and scientists by welcoming novel cohort studies, early-phase clinical trials, qualitative and quantitative epidemiologic research, hypothesis-generating research, and studies of novel mechanisms and methodologies including public health interventions. CTG also welcomes hypothesis-generating studies, methods papers, and translational research with clear applications to human physiological processes or diseases involving the gastrointestinal system. CTG adopts the National Institutes of Health’s (NIH) definition of translational research:

    Translational research includes two areas of translation. One is the process of applying discoveries generated during research in the laboratory, and in preclinical studies, to the development of trials and studies in humans. The second area of translation concerns research aimed at enhancing the adoption of best practices in the community. Cost-effectiveness of prevention and treatment strategies is also an important part of translational science1.

    This definition therefore requires the application of findings to human subjects, either directly or indirectly. Basic science research, particularly research involving animal models or in-vitro work, is best reported elsewhere. CTG expands the scope of translational research to include public health dimensions that impact the human experience. CTG devotes itself to publishing timely medical research in gastroenterology, pancreatology and hepatology with:

    Original Research Articles

    Review Articles

    Brief Report

    The Clinician’s Toolbox: Understanding our Tests (a structured assessment of individual diagnostic tests used in gastroenterology, pancreatology and hepatology)

    Editorials

    Correspondence

    MANUSCRIPT SUBMISSION

    Submissions are not accepted via email. Manuscripts must be submitted online at https://www.editorialmanager.com/ctg

    First-time Users: Please click the Register button in the main menu and enter the requested information. Upon successful registration, you will be sent an email indicating your username and password. Save a copy of this information for future reference. Note: If you have received an email from us with an assigned user ID and password, or if you are a repeat user, do not register again. Once you have an assigned ID and password, you do not need to re-register, even if your role changes (that is, author, reviewer, or editor). Authors please click the login button from the menu at the top of the page and log in to the system as an Author. Submit your manuscript according to the system instructions. You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact the Editorial Office (or click on the 'Contact Us' link in the header menu).

    ETHICAL AND LEGAL CONSIDERATIONS

    A submitted manuscript must be an original contribution not previously published (except as an abstract), must not be under consideration for publication elsewhere, and, if accepted, it must not be published elsewhere in similar form, in any language, without the consent of Wolters Kluwer. The Journal follows the ICJME recommendations for authorship. Any person listed as an author is expected to have participated in the study to a significant extent. Although editors and reviewers make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher.

    Documented review and approval from a formally constituted review board (Institutional Review Board or Ethics committee) is required for all studies involving people, medical records, and human tissues, and for all animal studies. For authors or investigators that do not have access to formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. If the study is judged exempt from review, a statement from the committee should be provided. Informed consent by participants should always be sought and documented in the Methods section. If not possible, an institutional review board must decide if this is ethically acceptable, and documentation of this decision must be included with the submission. In the main manuscript, a general IRB approval statement should be included. A more detailed statement that includes the name of the approving institution must be included on the title page.

    ……

    更多详情:

    https://edmgr.ovid.com/ctg/accounts/ifauth.htm



欢迎点评!让信息更透明,使投稿更轻松!
  • 审稿时间:
    是否录用:
  • 见刊周期:
    查重要求:
  • 有无课题:
    有无回复:
  • 我的学历:
    我的职称:
  • 审稿费用:
    版面费用:
  • 稿       费:
    稿件字数:
  • 投稿难度:
  • 该刊可发:
  • 投稿主题:
匿名: 验证码: 点击切换验证码
    评分:0

    验证码: 点击切换验证码